The ameliorative effect of sophoricoside on mast cell-mediated allergic inflammation in vivo and in vitro

Molecules

Volumn 18, Issue 5, 2013, Pages 6113-6127

  Kim, Su Jin ^a   Lee, Gil Yong ^a   Jung, Ji Wook ^a   Oh, Sa Rang ^b   Ahn, Eun Mi ^a   Kim, Sung Hoon ^c   Hong, Seung Heon ^d   Um, Jae Young ^c  

^a Daegu Haany University   (South Korea)

^b Keimyung University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Wonkwang University   (South Korea)

Author keywords

Allergic inflammation; Inflammatory cytokine; Mast cells; Sophoricoside

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ANTIINFLAMMATORY AGENT; BENZOPYRAN DERIVATIVE; CALCIMYCIN; CALCIUM IONOPHORE; CARCINOGEN; CYTOKINE; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; IRRITANT AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; SOPHORICOSIDE;

ANIMAL; ARTICLE; ATOPIC DERMATITIS; BAGG ALBINO MOUSE; CELL LINE; CHEMICALLY INDUCED DISORDER; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MAST CELL; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZOPYRANS; CALCIMYCIN; CALCIUM IONOPHORES; CARCINOGENS; CASPASE 1; CELL LINE; CYTOKINES; DERMATITIS, ATOPIC; DINITROCHLOROBENZENE; HISTAMINE; HUMANS; IRRITANTS; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; NF-KAPPA B; TETRADECANOYLPHORBOL ACETATE;

EID: 84878306562     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules18056113     Document Type: Article

References (29)

1. Buske-Kirschbaum, A.; Geiben, A.; Hellhammer, D. Psychobiological aspects of atopic dermatitis: an overview. Psychother. Psychosom. 2001, 70, 6-16. (Pubitemid 32041457)
2. Gold, M.S.; Kemp, A.S. Atopic disease in childhood. Med. J. Aust. 2005, 182, 298-304.
3. Trefzer, U.; Hofmann, M.; Sterry, W.; Asadullah, K. Cytokine and anti-cytokine therapy in dermatology. Expert Opin. Biol. Ther. 2003, 3, 733-743.
4. Tegeder, I.; Pfeilschifter, J.; Geisslinger, G. Cyclooxygenase- independent actions of cyclooxygenase inhibitors. FASEB J. 2001, 15, 2057-2072. (Pubitemid 32927924)
5. Gadaleta, R.M.; Oldenburg, B.; Willemsen, E.C.; Spit, M.; Murzilli, S.; Salvatore, L.; Klomp, L.W.; Siersema, P.D.; van Erpecum, K.J.; van Mil, S.W. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine. Biochim. Biophys. Acta 2011, 1812, 851-858.
6. Mukaida, N. Interleukin-8: An expanding universe beyond neutrophil chemotaxis and activation. Int. J. Hematol. 2000, 72, 391-398.
7. Lee, S.H.; Stehlik, C.; Reed, J.C. Cop, a caspase recruitment domaincontaining protein and inhibitor of caspase-1 activation processing. J. Biol. Chem. 2001, 276, 34495-34500.
8. Wang, X.; Wang, H.; Figueroa, B.E.; Zhang, W.H.; Huo, C.; Guan, Y.; Zhang, Y.; Bruey, J.M.; Reed, J.C.; Friedlander, R.M. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in huntington's disease. J. Neurosci. 2005, 25, 11645-11654. (Pubitemid 43098457)
9. Faubel, S.; Lewis, E.C.; Reznikov, L.; Ljubanovic, D.; Hoke, T.S.; Somerset, H.; Oh, D.J.; Lu, L.; Klein, C.L.; Dinarello, C.A.; et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J. Pharmacol. Exp. Ther. 2007, 322, 8-15. (Pubitemid 46956357)
10. Kim, B.H.; Chung, E.Y.; Min, B.K.; Lee, S.H.; Kim, M.K.; Min, K.R.; Kim, Y. Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activity. Planta Med. 2003, 69, 474-476. (Pubitemid 36774195)
11. Fiedor, P.; Kozerski, L.; Dobrowolski, J.C.; Kawecki, R.; Biniecki, K.; Pachecka, J.; Rowiński, W.; Mazurek, A.P. Immunosuppressive effects of synthetic derivative of genistein on the survival of pancreatic islet allografts. Transplant. Proc. 1998, 30, 537-538.
12. Wu, J.; Yang, X.; Ge, J.; Zhang, Y.; Wu, L.; Liu, J.; Zhang, X. Biotransformation of sophoricoside in Fructus sophorae by the fungus Schizophyllum commune. Bioresour. Technol. 2012. 111, 496-499.
13. Jung, SH.; Cho, S.H.; Dang, T.H.; Lee, J.H.; Ju, J.H.; Kim, M.K.; Lee, S.H.; Ryu, J.C.; Kim, Y. Structural requirement of isoflavonones for the inhibitory activity of interleukin-5. Eur. J. Med. Chem. 2003, 38, 537-545. (Pubitemid 36588921)
14. Du, N.; Xu, Y.; Chen, W.Z.; Zhang, F.H. Effect of Sophoricoside on histomorphology of bone in ovariectomized rats. Zhong Xi Yi Jie He Xue Bao 2003, 1, 44-46.
15. Humke, E.W.; Shriver, S.K.; Starovasnik, M.A.; Fairbrother, W.J.; Dixit, V.M. ICEBERG: A novel inhibitor of interleukin-1 generation. Cell 2000, 103, 99-111.
16. Leung, D.Y.; Bieber, T. Atopic dermatitis. Lancet 2003, 361, 151-160. (Pubitemid 36092023)
17. Shiohara, T.; Hayakawa, J.; Mizukawa, Y. Animal models for atopic dermatitis: Are they relevant to human disease? J. Dermatol. Sci. 2004, 36, 1-9. (Pubitemid 39370020)
18. Allam, J.P.; Novak, N. The pathophysiology of atopic eczema. Clin. Exp. Dermatol. 2006, 31, 89-93.
19. Brenninkmeijer, E.E.; Spuls, P.I.; Legierse, C.M.; Lindeboom, R.; Smitt, J.H.; Bos, J.D. Clinical differences between atopic and atopiform dermatitis. J. Am. Acad. Dermatol. 2008, 58, 407-414. (Pubitemid 351226310)
20. Lee, H.K.; Kim, H.S.; Kim, Y.J.; Kim, J.S.; Park, Y.S.; Kang, J.S.; Yuk, D.Y.; Hong, J.T.; Kim, Y.; Han, S.B. Sophoricoside isolated from Sophora japonica ameliorates contact dermatitis by inhibiting NF-κB signaling in B cells. Int. Immunopharmacol. 2013, 15, 467-473.
21. Minami, K.; Kamei, C. A chronic model for evaluating the itching associated with allergic conjunctivitis in rats. Int. Immunopharmacol. 2004, 4, 101-108. (Pubitemid 38223819)
22. Harvima, I.T.; Nilsson, G. Mast cells as regulators of skin inflammation and immunity. Acta Derm. Venereol. 2011, 91, 644-650.
23. Galli, S.J.; Kalesnikoff, J.; Grimbaldeston, M.A.; Piliponsky, A.M.; Williams, C.M.; Tsai, M. Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annu. Rev. Immunol. 2005. 23, 749-786. (Pubitemid 40563184)
24. Bunikowski, R.; Gerhold, K.; Bräutigam, M.; Hamelmann, E.; Renz, H.; Wahn, U. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int. Arch. Allergy Immunol. 2001. 125, 344-348. (Pubitemid 34704647)
25. Gilmore, T.D.; Garbati, M.R. Inhibition of NF-κB signaling as a strategy in disease therapy. Curr. Top. Microbiol. Immunol. 2011, 349, 245-263.
26. Lamkanfi, M.; Kalai, M.; Saelens, X.; Declercq, W.; Vandenabeele, P. Caspase-1 activates nuclear factor of the kappaenhancer in B cells independently of its enzymatic activity. J. Biol. Chem. 2004, 279. 24785-24793. (Pubitemid 38725346)
27. Sugimoto, Y.; Umakoshi, K.; Nojiri, N.; Kamei, C. Effect of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice. Eur. J. Pharmacol. 1998, 351, 1-5. (Pubitemid 28300296)
28. Gao, X.K.; Fuseda, K.; Shibata, T.; Tanaka, H.; Inagaki, N.; Nagai, H. Kampo medicines for mite antigen-induced allergic dermatitis in NC/Nga mice. Evid. Based. Complement Alterna. Med. 2005. 2, 191-199. (Pubitemid 41399492)
29. Schoonbroodt, S.; Legrand-Poels, S.; Best-Belpomme, M.; Piette, J. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 1997, 321, 777-785. (Pubitemid 27084888)